Category Archives: Stem Cell Research

Speech 1010- Persuasive Speech- Stem Cell Research Angad SPeech. By: MrAngaddeep … Continue reading →

The exact nature and properties of mesenchymal stem cells remain unclear. STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY Pamela Robey is used to being sent samples by scientists who are anxious to know whether the mesenchymal stem cells (MSCs) they have extracted from fat can be coaxed to turn into either bone or cartilage. Robey, who directs the Stem Cell Unit at the US National Institutes of Health (NIH), is also used to delivering bad news to many of those who seek her help. They usually are not happy, she says, when her attempts to differentiate the cells produce little more than fatty globules. To Robey, that disappointment reflects a pervasive misunderstanding about what MSCs are and what they can do one that is fuelled by a lack of information. MSCs have been proposed as treatments for a wide range of ailments including heart and brain injury, joint damage, Crohns disease and multiple sclerosis. But some scientists say that these clinical aspirations have far outrun the basic science. It always seems a little bit like hocus pocus when youre treating everything from skeletal to immunological disorders, says George Daley, director of the Stem Cell Transplantation Program at Boston Childrens Hospital in Massachusetts. An … Continue reading →

SACRAMENTO, Calif. (PRWEB) July 23, 2013 One of regenerative medicines greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons the primary movers of electrical impulses in the brain to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task. Published today in the journal Nature Communications, the large, collaborative study found that astrocytes neural cells that transport key nutrients and form the blood-brain barrier can protect brain tissue and reduce disability due to stroke and other ischemic brain disorders. "Astrocytes are often considered just housekeeping cells because of their supportive roles to neurons, but theyre actually much more sophisticated," said Wenbin Deng, associate professor of biochemistry and molecular medicine at UC Davis and senior author of the study. "They are critical to several brain functions and are believed to protect neurons from injury and death. They are not excitable cells like neurons and are easier to harness. We wanted to explore their potential in treating neurological disorders, beginning with stroke." Deng … Continue reading →

Public release date: 23-Jul-2013 [ | E-mail | Share ] Contact: Charles Casey charles.casey@ucdmc.ucdavis.edu 916-734-9048 University of California - Davis Health System (SACRAMENTO, Calif.) -- One of regenerative medicine's greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons the primary movers of electrical impulses in the brain to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task. Published July 23 in the journal Nature Communications, the large, collaborative study found that astrocytes neural cells that transport key nutrients and form the blood-brain barrier can protect brain tissue and reduce disability due to stroke and other ischemic brain disorders. "Astrocytes are often considered just 'housekeeping' cells because of their supportive roles to neurons, but they're actually much more sophisticated," said Wenbin Deng, associate professor of biochemistry and molecular medicine at UC Davis and senior author of the study. "They are critical to several brain functions and are believed to protect neurons from injury and death. They are not excitable cells like … Continue reading →

TORONTO, ONTARIO--(Marketwired - Jul 23, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(SCTPF), a biopharmaceutical company developing cancer stem cell-related therapeutics, today announced the appointment of ProActive Capital Group as its new Capital Markets Advisory and Digital Media Strategies firm. "We are very pleased to have retained the services of ProActive Capital Group," stated Stem Cell Therapeutics' Chief Executive Officer, Dr. Niclas Stiernholm. "They are an extremely focused firm with an excellent reputation in the industry and we are excited to adopt an effective capital markets and digital media program. With upcoming key milestones quickly approaching, we feel that now is the opportune time to embark on a significant new and expanded program so that we can achieve a fair valuation that clearly reflects the intrinsic value of our scientific programs." "We are delighted to have been selected by Stem Cell Therapeutics, a leading company in the cancer stem cell space," stated Jeff Ramson, Founder and CEO of ProActive Capital Group. "We look forward to developing and implementing a quality capital markets and digital media strategy to increase SCT's visibility among the investment community. We strongly believe that the company has significant prospects as it executes its growth strategy." The … Continue reading →

Jacqueline Liu - High School Stem Cell Research Intern - Summer 2013 (CIRM Creativity Award) Jacqueline Liu is a Davis Senior High School student doing a stem cell research internship this summer in the laboratory of Gerhard Bauer at UC Davis. Her in... By: California Institute for Regenerative Medicine … Continue reading →

A Surrey-based firm specialising in stem cell research is to relocate to Wales. ReNeuron has been based in Guildford, Surrey, since being founded in 1997 and markets itself as a "leading clinical-stage" business. But it will make the move across the border after securing 33.2 million to boost its operations. Of that figure, 5 million has come via the taxpayer-backed Wales Life Sciences Investment Fund and a 7.8 million grant from the Welsh Government. Business minister Edwina Hart welcomed the news saying life sciences could become a key sector in the principality's economy, adding: "I am delighted by the news that ReNeuron has decided to move to Wales. "ReNeuron is the first company in the world to have been granted permission to run clinical trials of ground-breaking stem cell technology to treat patients with stroke, one of the top three causes of death and a leading cause of adult disability in Wales. This is the second investment made by the Wales Life Sciences Investment Fund, a key component in our strategy to support the growth of the life sciences sector in Wales - one of our key priority sectors with the potential to make a significant contribution to the Welsh … Continue reading →

22 July 2013 Last updated at 10:49 ET A medical company is due to relocate to south Wales after securing 33.2m to continue its research into stem cells which can repair damaged tissue. ReNeuron has received almost 13m in Welsh government grants and investments as part of its move from Guildford. Minister Edwina Hart said life sciences was a key business sector with the "potential to make a significant contribution to the Welsh economy". The company is working on treatment for stroke patients. Bosses are planning to relocate to south Wales over the next two years, bringing 25 jobs and possibly expanding to employ about 70 people. Sir Chris Evans has made a career and a fortune out of starting up and building medical companies. He has a rare combination of skills which include a scientific background as a microbiologist and a hard-nosed sense of finance and profits. He says the companies he's set up over a 20 year period employ nearly 5,000 people in the UK. Much of his work has been in the Cambridgeshire area but Economy Minister Edwina Hart is hoping his expertise can be used to benefit the Welsh medical technology and pharmaceutical industry, running Wales' … Continue reading →

Editor's Choice Academic Journal Main Category: Stem Cell Research Also Included In: Biology / Biochemistry Article Date: 19 Jul 2013 - 5:00 PDT Current ratings for: Scientists develop safe and easy way to make stem cells 3.5 (4 votes) By using a cocktail of small molecules to chemically reprogram the adult tissue cells they say they can make induced pluripotent stem cells (iPSCs) as versatile as embryonic stem cells, without running the risk of dangerous mutations or cancer that occurs when gene insertion is used to make iPS cells. The chemical insertion method of inducing cells used by these researchers is simpler and easier than the gene insertion approach, which, they note, has also tended to limit the clinical application of iPS cells. For their study, Deng Hongkui, a professor and stem-cell biologist at Peking University in Beijing, and colleagues, induced a pluripotent state in adult cells from mice using seven small-molecule compounds. They started out by screening 10,000 small molecules. They were looking for a combination that would have the same effect as gene insertion. They then had to work for another year fine-tuning the cocktail to achieve the hallmark of pluripotency and also to increase the efficiency of … Continue reading →

The Golden Era of Stem Cell Discoveries: Una Riekstina at TEDxRiga 2013 Una Riekstina is dedicating her life in the stem cell research. She got her PhD at Karolinska Institutet, in Stockholm. Currently she is Asoc. Professor and ... By: TEDxTalks … Continue reading →